Albert David Limited reported audited financial results for the quarter and financial year ended March 31, 2026, posting a net loss of ₹149.47 lakh for the full year. This represents a significant reversal from the net profit of ₹1720.08 lakh recorded in the previous fiscal year. Revenue from operations for FY26 stood at ₹33359.81 lakh, declining from ₹34576.80 lakh in FY25. Total income for FY26 was ₹34105.14 lakh against ₹37534.87 lakh in FY25, while total expenses were ₹34052.65 lakh compared to ₹35012.10 lakh previously. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on May 12, 2026.

Quarterly Performance

For the quarter ended March 31, 2026, Albert David reported a net loss of ₹2143.44 lakh, widening from a net loss of ₹1032.79 lakh in the corresponding quarter of the prior year. Revenue from operations for the quarter was ₹8586.34 lakh, compared to ₹7489.33 lakh in the same period last year. Total income for the quarter stood at ₹6102.50 lakh, while total expenses amounted to ₹8625.88 lakh. The loss before tax for the quarter was ₹2523.38 lakh, against a loss before tax of ₹1180.87 lakh in the year-ago quarter. The figures for the quarter ended March 31, 2026 represent the balancing figure between the audited full-year figures and the published unaudited year-to-date figures up to the third quarter.

Financial Performance Summary

The following table presents the key financial metrics for the full year and the latest quarter:

Balance Sheet Highlights

The statement of assets and liabilities as of March 31, 2026, showed total assets at ₹51913.28 lakh, a slight increase from ₹51141.56 lakh in the previous year. Total equity stood at ₹39153.63 lakh as against ₹39248.34 lakh in the prior year, comprising equity share capital of ₹570.72 lakh and other equity of ₹38582.91 lakh. Total current assets were ₹37440.29 lakh, while total current liabilities stood at ₹11543.02 lakh. Current borrowings rose to ₹2847.76 lakh from ₹1004.92 lakh in the previous year.

Cash Flow Overview

The company's cash flow statement for the year ended March 31, 2026, showed net cash used in operating activities of ₹765.85 lakh, compared to ₹2843.58 lakh in the prior year. Net cash used in investing activities was ₹439.98 lakh, while net cash from financing activities stood at ₹1192.16 lakh. Closing cash and cash equivalents were ₹29.91 lakh, down from ₹41.73 lakh at the start of the year. The cash flow statement was prepared under the indirect method as per Ind AS-7.

Audit Opinion and Dividend

M/s. L. B. Jha & Co., Chartered Accountants (Firm Registration No. 301088E/E300295), Statutory Auditors of the company, issued the Audit Report with an unmodified opinion on the financial results for the quarter and year ended March 31, 2026. The audit was signed by Partner Ranjan Singh (Membership No. 305423) at Kolkata on May 12, 2026. The Board of Directors recommended a final dividend of ₹5.00 per share of face value ₹10 each for the financial year ended March 31, 2026, subject to approval of shareholders at the 87th Annual General Meeting. The company has fixed July 30, 2026, as the record date for determining eligibility for the dividend and voting at the AGM. The register of members and share transfer books will remain closed from July 31, 2026, to August 6, 2026.

Board Decisions and Appointments

The Board appointed Mr. Amit Mahla as the Chief Executive Officer (CEO) of the company with effect from May 12, 2026, following the resignation of Mr. Umesh Manohar Kunte from the post of Managing Director & CEO. Mr. Mahla, aged approximately 52 years, brings over 28 years of experience in the pharmaceutical industry and has previously been associated with organisations including Cipla, Emcure, Glenmark, Alembic, Sun Pharma, and JB Pharma. He holds a degree in Science, a postgraduate degree in English Literature, and an Executive MBA from SIES, Mumbai. The board also re-appointed M/s. PricewaterhouseCoopers Services LLP as Internal Auditors and M/s. S. Gupta & Co. as Cost Auditors for the financial year 2026-27. The 87th AGM is scheduled to be held on August 6, 2026, via video conferencing.

Albert David Limited has intimated the stock exchanges about a scheduled meeting of its Board of Directors to be held on Tuesday, May 12, 2026. The meeting has been convened in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for Board Meeting

The Board of Directors will consider the following key matters during the meeting:

• Consider, approve and take on record the Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended on March 31, 2026
• Consider recommendation of Final Dividend, if any, for the Financial Year ended on March 31, 2026

Trading Window Closure

The company has announced that the trading window for dealing in equity shares of the company is currently closed. The window was closed from April 1, 2026, and shall reopen 48 hours after the declaration of the financial results.

Key Details

The notice has been addressed to the General Manager of the Department of Corporate Services at BSE Limited and the Manager - Listing Department at the National Stock Exchange of India Limited. The intimation was signed by Lalit Lohia, Company Secretary & Compliance Officer, on May 4, 2026. The notice is also available on the company's official website at www.albertdavidindia.com .